The Effect of Pseudomonas aeruginosa Infection on Clinical Parameters in Steady-State Bronchiectasis

Chest

Volumn 114, Issue 6, 1998, Pages 1594-1598

  Ho, Pak Leung ^a   Chan, Kwok Ning ^b   Ip, Mary S M ^b   Lam, Wah Kit ^b   Ho, Chu Sek ^b   Yuen, Kwok Yung ^b   Tsang, Kenneth W T ^a,b  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Bronchiectasis; Pseudomonas aeruginosa; Sputum pathogens

Indexed keywords

ADULT; AGED; ARTICLE; ASIAN; BRONCHIECTASIS; CHINA; CROSS-SECTIONAL STUDY; ETHNOLOGY; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; ISOLATION AND PURIFICATION; LUNG FUNCTION TEST; MALE; MICROBIOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; SPUTUM;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BRONCHIECTASIS; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY FUNCTION TESTS; SPUTUM;

EID: 0032253292     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.6.1594     Document Type: Article

References (18)

1. Cole PJ. Bronchiectasis. In: Brewis RAL, Corrin B, Geddes DM, eds. Respiratory medicine. London: Saunders, 1995; 1286-1317
2. Chan TH, Ho SS, Lai CKW, et al. Comparison of oral ciprofloxacin and amoxycillin in treating infective exacerbations of bronchiectasis in Hong Kong. Chemotherapy 1996; 42:150-156
3. Rayner CFJ, Tillotson G, Cole PJ, et al. Efficacy and safety of long term ciprofloxacin in the management of severe bronchiectasis. J Antimicrob Chemother 1994; 34:149-156
4. Nicotra MB, Rivera M, Dale AM, et al. Clinical, pathological, and microbiological characterization of bronchiectasis in an aging cohort. Chest 1995; 108:955-961
5. American Thoracic Society. Evaluation of impairment/disability secondary to respiratory disorders: a statement of the American Thoracic Society. Am Rev Respir Dis 1986; 133: 1205-1209
6. Lam WK, Chau PY, So SY, et al. Ofloxacin compared with amoxycillin in treating infective exacerbations in bronchiectasis. Respir Med 1989; 83:300-303
7. Deneuville E, Perrot-Minot C, Pennaforte F, et al. Revisited physiochemical and transport properties of respiratory mucus in genotyped cystic fibrosis patients. Am J Respir Crit Care Med 1997; 156:166-172
8. Tsang KWT, Lam SK, Lam WK, et al. High sero-prevalence of Helicobacter pylori in bronchiectasis [abstract]. Eur Respir J 1997; 10(suppl 25):147s
9. Bartlett JG, Ryan KJ, Wilson WR. Laboratory diagnosis of lower respiratory tract infections. In: Washington JA II, eds. Cumulative techniques and procedures in clinical microbiology. Washington, DC: American Society for Microbiology, 1987; 1-18
10. Durrie DC, Higgs E, Metcalfe S, et al. Simple method of monitoring colonising microbial load in chronic sepsis: pilot comparison of reduction in colonising microbial load with antibiotics given intermittently and continuously. J Clin Pathol 1987; 40:830-836
11. SAS Institute. Statistical Analysis System user's guide (statistics version). 5th ed. Cary, NC: SAS Institute, 1995
12. Hill SL, Morrison HM, Burnett D, et al. Short term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally and by inhalation. Thorax 1986; 41:559-565
13. Hill SL, Bilton D, Johnson M, et al. Sputum and serum pharmacokinetics of loracarbef (LY163892) in patients with chronic bronchial sepsis. J Antimicrob Chemother 1994; 33:129-136
14. May JR. The chemotherapy of chronic bronchitis and allied disorders. 2nd ed. London: English Universities Press, 1972
15. Evans SA, Turner SM, Bosch BJ, et al. Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa. Eur Respir J 1996; 9:1601-1604
16. Nagaki M, Shimura S, Tanno Y, et al. Role of chronic Pseudomonas aeruginosa infection in the development of bronchiectasis. Chest 1992; 102:1464-1469
17. Song JH, and the Asian Network for Surveillance of Resistant Pneumococci (ANSORP) Study Group. Prevalence of drug-resistant pneumococci in 11 Asian countries. In: Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1997; Abstract C48, p. 54
18. Ho PL, Yuen KY, Yam WC, et al. Changing patterns of susceptibilities of blood, urinary and respiratory pathogens in Hong Kong. J Hosp Infect 1995; 31:305-317